RELORN Trademark

Trademark Overview

On Wednesday, February 26, 2020, a trademark application was filed for RELORN with the United States Patent and Trademark Office. The USPTO has given the RELORN trademark a serial number of 88811401. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, June 21, 2023. This trademark is owned by Unipharm, Inc.. The RELORN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for pain relief and fever reduction
relorn

General Information

Serial Number88811401
Word MarkRELORN
Filing DateWednesday, February 26, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, June 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and ServicesPharmaceuticals for pain relief and fever reduction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, June 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUnipharm, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10118
Party NameUnipharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10118

Trademark Events

Event DateEvent Description
Wednesday, June 21, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, June 21, 2023ABANDONMENT - AFTER PUBLICATION
Tuesday, June 20, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, February 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2023SOU EXTENSION 5 GRANTED
Wednesday, February 8, 2023SOU EXTENSION 5 FILED
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU EXTENSION 4 GRANTED
Tuesday, August 23, 2022SOU EXTENSION 4 FILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2022SOU EXTENSION 3 GRANTED
Thursday, February 17, 2022SOU EXTENSION 3 FILED
Thursday, February 17, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2021SOU EXTENSION 2 GRANTED
Thursday, August 12, 2021SOU EXTENSION 2 FILED
Thursday, August 12, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 19, 2021SOU EXTENSION 1 GRANTED
Friday, February 19, 2021SOU EXTENSION 1 FILED
Friday, February 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2020ASSIGNED TO LIE
Monday, May 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 18, 2020EXAMINER'S AMENDMENT ENTERED
Monday, May 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 18, 2020EXAMINERS AMENDMENT E-MAILED
Monday, May 18, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, May 15, 2020ASSIGNED TO EXAMINER
Thursday, March 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

relorn reduction fever relief pain pharmaceuticals